- Home
- CUB vs ALDX Comparison
CUB vs ALDX Comparison
Compare CUB & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUB
- ALDX
- Stock Information
- Founded
- CUB 2024
- ALDX 2004
- Country
- CUB United States
- ALDX United States
- Employees
- CUB N/A
- ALDX N/A
- Industry
- CUB
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- CUB
- ALDX Health Care
- Exchange
- CUB NYSE
- ALDX Nasdaq
- Market Cap
- CUB 310.3M
- ALDX 319.4M
- IPO Year
- CUB 2024
- ALDX 2014
- Fundamental
- Price
- CUB $10.11
- ALDX $4.89
- Analyst Decision
- CUB
- ALDX Strong Buy
- Analyst Count
- CUB 0
- ALDX 2
- Target Price
- CUB N/A
- ALDX $10.00
- AVG Volume (30 Days)
- CUB 33.7K
- ALDX 394.1K
- Earning Date
- CUB 01-01-0001
- ALDX 03-06-2025
- Dividend Yield
- CUB N/A
- ALDX N/A
- EPS Growth
- CUB N/A
- ALDX N/A
- EPS
- CUB N/A
- ALDX N/A
- Revenue
- CUB N/A
- ALDX N/A
- Revenue This Year
- CUB N/A
- ALDX N/A
- Revenue Next Year
- CUB N/A
- ALDX N/A
- P/E Ratio
- CUB N/A
- ALDX N/A
- Revenue Growth
- CUB N/A
- ALDX N/A
- 52 Week Low
- CUB $9.96
- ALDX $2.71
- 52 Week High
- CUB $10.55
- ALDX $6.55
- Technical
- Relative Strength Index (RSI)
- CUB N/A
- ALDX 47.68
- Support Level
- CUB N/A
- ALDX $4.74
- Resistance Level
- CUB N/A
- ALDX $5.05
- Average True Range (ATR)
- CUB 0.00
- ALDX 0.26
- MACD
- CUB 0.00
- ALDX -0.02
- Stochastic Oscillator
- CUB 0.00
- ALDX 25.00
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.